Table VII.
Adverse events reported by the study subjects (no. [%] of study subjects) during the 6-week supplementation period.
Treatment Group (n = 11) | Placebo Group (n = 11) | |
---|---|---|
Constipation | 1 (9.1) | 0 |
Headache | 1 (9.1) | 0 |
Indigestion | 1 (9.1) | 0 |
Dry mouth | 0 | 1 (9.1) |
Irritability | 0 | 1 (9.1) |
Nausea | 0 | 1 (9.1) |
Total events | 3 | 3 |